Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Benitec Biopharma (BNTC) Equity Ratio (2019 - 2025)

Benitec Biopharma has reported Equity Ratio over the past 7 years, most recently at 0.98 for Q4 2025.

  • Quarterly results put Equity Ratio at 0.98 for Q4 2025, up 7769032.5% from a year ago — trailing twelve months through Dec 2025 was 0.98 (up 7769032.5% YoY), and the annual figure for FY2025 was 0.98, up 7.95%.
  • Equity Ratio reached 0.98 in Q4 2025 per BNTC's latest filing, up from 0.97 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.98 in Q4 2025 and bottomed at 2.84 in Q3 2024.
  • Median Equity Ratio over the past 5 years was 0.77 (2021), compared with a mean of 0.4.
  • The largest annual shift saw Equity Ratio crashed 444.41% in 2024 before it skyrocketed 7769032.5% in 2025.
  • Over 5 years, Equity Ratio stood at 0.77 in 2021, then dropped by 2.3% to 0.76 in 2022, then decreased by 4.1% to 0.72 in 2023, then crashed by 100.0% to 0.0 in 2024, then surged by 7769032.5% to 0.98 in 2025.
  • Business Quant data shows Equity Ratio for BNTC at 0.98 in Q4 2025, 0.97 in Q3 2025, and 0.98 in Q2 2025.